These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 53994)

  • 1. Long-term treatment of ventricular arrhythmias with oral mexiletine.
    Talbot RG; Julian DG; Prescott LF
    Am Heart J; 1976 Jan; 91(1):58-65. PubMed ID: 53994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mexiletine: long-term efficacy and hemodynamic actions in patients with ventricular arrhythmia.
    Sami M; Lisbona R
    Can J Cardiol; 1985; 1(4):251-8. PubMed ID: 2413974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of mexiletine in arrhythmia of effort].
    Zacà F; Cremonesi A; Pagliarani PL; Guelfi P; Bugiardini R; Lasagna I; Ghinelli M; Luciani G
    Minerva Cardioangiol; 1981 Nov; 29(11):655-60. PubMed ID: 6173818
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of oral mexiletine therapy in the treatment of ventricular arrhythmias.
    Rutledge JC; Harris F; Amsterdam EA
    J Am Coll Cardiol; 1985 Oct; 6(4):780-4. PubMed ID: 4031292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mexiletine in the treatment of ventricular arrhythmias (author's transl)].
    Schlemmer M; Wimmer M
    Padiatr Padol; 1982; 17(2):383-9. PubMed ID: 6179031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction.
    Campbell RW; Dolder MA; Prescott LF; Talbot RG; Murray A; Julian DG
    Lancet; 1975 Jun; 1(7919):1257-60. PubMed ID: 48894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of rhythm disorders of ventricular origin with KO 1173 (Mexiletin) (author's transl)].
    Esser H; Kikis D
    Med Klin; 1977 Sep; 72(35):1386-91. PubMed ID: 71652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mexiletine (Kö 1173) in the management of ventricular dysrhythmias.
    Campbell NP; Kelly JG; Shanks RG; Chaturvedi NC; Strong JE; Pantridge JF
    Lancet; 1973 Aug; 2(7826):404-7. PubMed ID: 4124890
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mexiletine in treatment of chronic ventricular refractary arrhythmias (author's transl)].
    Bellocci F; Ansalone G; Scabbia E; Santarelli P; Lucente M; Affinito V; Loperfido F; Zecchi P
    G Ital Cardiol; 1981; 11(4):488-97. PubMed ID: 6169580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical experience with mexiletine.
    Johansson BW; Stavenow L; Hanson A
    Am Heart J; 1984 May; 107(5 Pt 2):1099-102. PubMed ID: 6720535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mexiletine for ventricular arrhythmias.
    Podrid PJ; Lown B
    Am J Cardiol; 1981 Apr; 47(4):895-902. PubMed ID: 6782850
    [No Abstract]   [Full Text] [Related]  

  • 12. Conversion from intravenous to oral mexiletine in the acute management of repetitive ventricular arrhythmia.
    Horowitz LN; Greenspan AM; Spielman SR; Frye SJ; Yacone LA; Lowenthal DT
    Clin Pharmacol Ther; 1985 Jun; 37(6):644-8. PubMed ID: 2408808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ventricular arrhythmias with mexiletine (Kö 1173).
    Talbot RG; Nimmo J; Julian DG; Clark RA; Neilson JM; Prescott LF
    Lancet; 1973 Aug; 2(7826):399-404. PubMed ID: 4124889
    [No Abstract]   [Full Text] [Related]  

  • 14. Mexiletine therapy in patients with chronic drug-resistant malignant ventricular arrhythmias. Clinical efficacy, safety, and side effects.
    Haggman DL; Maloney JD; Morant VA; Castle LW; King-Rankine M; Goormastic M
    Cleve Clin Q; 1986; 53(2):171-9. PubMed ID: 2874902
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term oral antiarrhythmic therapy with mexiletine.
    Campbell NP; Pantridge JF; Adgey AA
    Br Heart J; 1978 Jul; 40(7):796-801. PubMed ID: 687477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of lignocaine and mexiletine on experimental ventricular arrhythmias.
    Allen JD; Kelly JG; James RG; Shanks RG; Zaidi SA
    Postgrad Med J; 1977; 53 Suppl 1():35-47. PubMed ID: 876952
    [No Abstract]   [Full Text] [Related]  

  • 17. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
    Flaker GC; Madigan NP; Alpert MA; Moser SA
    Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-arrhythmic effects of mexiletine].
    Ledain L; Page A; Favreau L; Besse P
    Arch Mal Coeur Vaiss; 1982 May; 75(5):605-12. PubMed ID: 6180692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of intravenous mexiletine on ventricular ectopic activity.
    Waleffe A; Kulbertus HE
    Acta Cardiol; 1977; 32(4):269-82. PubMed ID: 74154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term treatment of ventricular arrhythmias with oral mexiletine.
    Campbell RW; Julian DG; Talbot RG; Prescott LF
    Postgrad Med J; 1977; 53 Suppl 1():146-9. PubMed ID: 406605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.